EUDA Health (NASDAQ:EUDA) Posts Earnings Results, Beats Expectations By $0.76 EPS

EUDA Health (NASDAQ:EUDA) issued its quarterly earnings results on Tuesday. The company reported ($0.44) earnings per share for the quarter, beating analysts’ consensus estimates of ($1.20) by $0.76, FiscalAI reports. The firm had revenue of $1.92 million during the quarter, compared to the consensus estimate of $3.90 million.

EUDA Health Trading Up 2.1%

NASDAQ:EUDA traded up $0.27 during mid-day trading on Thursday, hitting $13.44. The stock had a trading volume of 25,250 shares, compared to its average volume of 93,461. The company has a 50 day simple moving average of $10.74 and a 200-day simple moving average of $32.04. EUDA Health has a 52 week low of $5.26 and a 52 week high of $86.00. The stock has a market capitalization of $33.80 million, a price-to-earnings ratio of -5.60 and a beta of 0.56.

Wall Street Analysts Forecast Growth

EUDA has been the subject of a number of research analyst reports. Greenridge Global lowered their price target on EUDA Health from $120.00 to $55.00 and set a “buy” rating for the company in a report on Monday, March 9th. Zacks Research downgraded EUDA Health from a “hold” rating to a “strong sell” rating in a report on Monday, March 23rd. Finally, Weiss Ratings reiterated a “sell (d)” rating on shares of EUDA Health in a report on Wednesday, April 8th. One analyst has rated the stock with a Buy rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Reduce” and a consensus target price of $55.00.

Institutional Investors Weigh In On EUDA Health

A hedge fund recently bought a new stake in EUDA Health stock. Jane Street Group LLC purchased a new position in EUDA Health Holdings Limited (NASDAQ:EUDA) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 25,675 shares of the company’s stock, valued at approximately $59,000. Jane Street Group LLC owned approximately 0.07% of EUDA Health as of its most recent filing with the Securities & Exchange Commission. 4.35% of the stock is currently owned by institutional investors and hedge funds.

About EUDA Health

EUDA Health, Inc (NASDAQ:EUDA) is a healthcare technology company focused on the development and commercialization of digital health solutions and energy-based medical devices for women’s intimate health. The company’s platform combines non-invasive treatment devices with software-driven patient monitoring and analytics to support pelvic floor function, address stress urinary incontinence and enhance vaginal tissue health.

EUDA Health’s core product offerings utilize low-intensity radiofrequency energy delivered through proprietary handpieces to promote tissue remodeling and muscle activation.